| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-15 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-14 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-13 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-08 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |